Astellas Pharma Global Development, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

First Posted Date
2012-08-08
Last Posted Date
2015-02-23
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
68
Registration Number
NCT01660477
Locations
🇺🇸

Parexel International, Glendale, California, United States

Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects

First Posted Date
2012-08-06
Last Posted Date
2012-08-28
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
20
Registration Number
NCT01657825
Locations
🇺🇸

Spaulding Clinical, West Bend, Wisconsin, United States

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects

First Posted Date
2012-08-06
Last Posted Date
2015-09-01
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
24
Registration Number
NCT01657838
Locations
🇺🇸

Spaulding Clinical, West Bend, Wisconsin, United States

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

First Posted Date
2012-08-06
Last Posted Date
2015-09-01
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
28
Registration Number
NCT01657890
Locations
🇺🇸

Parexel International, Glendale, California, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

First Posted Date
2012-07-27
Last Posted Date
2015-02-23
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
24
Registration Number
NCT01651325
Locations
🇺🇸

Parexel, Baltimore, Maryland, United States

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

First Posted Date
2012-07-26
Last Posted Date
2024-12-10
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
60
Registration Number
NCT01650194
Locations
🇺🇸

Site US2492 MD Anderson Cancer Ctr, Houston, Texas, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin

First Posted Date
2012-07-10
Last Posted Date
2015-02-23
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
24
Registration Number
NCT01635946
Locations
🇺🇸

Clinical Pharmacology of Miami, Miami, Florida, United States

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

First Posted Date
2012-07-10
Last Posted Date
2015-09-01
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
24
Registration Number
NCT01635972
Locations
🇺🇸

Clinical Pharmacology of Miami, Miami, Florida, United States

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

First Posted Date
2012-06-28
Last Posted Date
2024-11-13
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
252
Registration Number
NCT01630083
Locations
🇷🇺

Site RUS009, Kursk, Russian Federation

🇺🇦

Site UKR003, Dnipropetrovsk, Ukraine

🇺🇦

Site UKR007, Kyiv, Ukraine

and more 45 locations
© Copyright 2024. All Rights Reserved by MedPath